Literature DB >> 19465162

Phylogenetic designation of enterovirus 71 genotypes and subgenotypes using complete genome sequences.

Yoke-Fun Chan1, I-Ching Sam, Sazaly AbuBakar.   

Abstract

Human enterovirus 71 (EV-71) is genotyped for molecular epidemiological investigation mainly using the two structural genes, VP1 and VP4. Based on these, EV-71 is divided into three genotypes, A, B and C, and within the genotypes B and C, there are further subgenotypes, B1-B5 and C1-C5. Classification using these genes is useful but gives incomplete phylogenetic information. In the present study, the phylogenetic relationships amongst all the known EV-71 and human enterovirus A (HEV-A) isolates with complete genome sequences were examined. A different tree topology involving EV-71 isolates of subgenotypes, C4 and B5 was obtained in comparison to that drawn using VP1. The nucleotide sequence divergence of the C4 isolates was 18.11% (17-20%) when compared to other isolates of subgenotype C. However, this positions the C4 isolates within the cut-off divergence value of 17-22% used to designate the virus genotypes. Hence, it is proposed here that C4 should be designated as a new genotype D. In addition, the subgenotype B5 isolates had an average nucleotide divergence of only 6.14% (4-8%) when compared to other subgenotype B4 isolates. This places the B5 isolates within the subgenotype B4. It is proposed here that the B5 isolates to be redesignated as B4. With the newly proposed genotype D and inclusion of subgenotype B5 within B4, the average nucleotide divergence between genotypes was 18.99% (17-22%). Inter- and intra-subgenotype average divergences were 12.02% (10-14%) and 3.92% (1-10%), respectively. A phylogenetic tree built using the full genome sequences is robust as it takes into consideration changes in the sequences of both the structural and non-structural genes. Similar nucleotide similarities, however, were obtained if only VP1 and 3D RNA polymerase genes were used. Furthermore, addition of 3D RNA polymerase sequences will also show recombination events. Hence, in the absence of full genome sequences, it is proposed here that a combination of VP1 and 3D RNA polymerase gene sequences be used for initial genotyping of EV-71 isolates. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19465162     DOI: 10.1016/j.meegid.2009.05.010

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  49 in total

1.  Genetic analysis of the P1 region of human enterovirus 71 strains and expression of the 55 F strainVP1 protein.

Authors:  Jian-qiang Li; Jun-jie Yang; Xiu-juan Fan; Zhen-peng Sun; Yan Sun; Huan Li; Zi-xin Meng; Wei Li
Journal:  Virol Sin       Date:  2012-01-22       Impact factor: 4.327

2.  Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.

Authors:  Shilin Yuan; Guiming Li; Ying Wang; Qianqian Gao; Yizhuo Wang; Rui Cui; Ralf Altmeyer; Gang Zou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

3.  A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China.

Authors:  Yongjuan Liu; Chong Fu; Suying Wu; Xiong Chen; Yingying Shi; Bingfei Zhou; Lianglu Zhang; Fengfeng Zhang; Zhihao Wang; Yingying Zhang; Chengpeng Fan; Song Han; Jun Yin; Biwen Peng; Wanhong Liu; Xiaohua He
Journal:  Virus Genes       Date:  2014-01-19       Impact factor: 2.332

4.  Complete genome sequence analysis of two human coxsackievirus A9 strains isolated in Yunnan, China, in 2009.

Authors:  Jiansheng Liu; Yanju Zhu; Yue Pan; Zhengling Liu; Chen Guo; Shaohui Ma
Journal:  Virus Genes       Date:  2015-02-14       Impact factor: 2.332

5.  Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.

Authors:  Chee Wah Tan; Chit Laa Poh; I-Ching Sam; Yoke Fun Chan
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

6.  Antigenic and receptor binding properties of enterovirus 68.

Authors:  Tadatsugu Imamura; Michiko Okamoto; Shin-ichi Nakakita; Akira Suzuki; Mariko Saito; Raita Tamaki; Socorro Lupisan; Chandra Nath Roy; Hiroaki Hiramatsu; Kan-etsu Sugawara; Katsumi Mizuta; Yoko Matsuzaki; Yasuo Suzuki; Hitoshi Oshitani
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

7.  Characterization of full-length enterovirus 71 strains from severe and mild disease patients in northeastern China.

Authors:  Xiaomei Wang; Chunfeng Zhu; Wanguo Bao; Ke Zhao; Junqi Niu; Xiao-Fang Yu; Wenyan Zhang
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

Review 8.  Challenges to licensure of enterovirus 71 vaccines.

Authors:  Min-Shi Lee; Fan-Chen Tseng; Jen-Ren Wang; Chia-Yu Chi; Pele Chong; Ih-Jen Su
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

9.  Immunological evaluation and comparison of different EV71 vaccine candidates.

Authors:  Ai-Hsiang Chou; Chia-Chyi Liu; Jui-Yuan Chang; Shu-Pei Lien; Meng-Shin Guo; Hau-Pong Tasi; Kuang-Nan Hsiao; Shih-Jen Liu; Charles Sia; Suh-Chin Wu; Min-Shi Lee; Chia-Hsin Hsiao; Jen-Ren Wang; Yen-Hung Chow; Pele Chong
Journal:  Clin Dev Immunol       Date:  2012-09-12

10.  Cross-reactive neutralizing antibody responses to enterovirus 71 infections in young children: implications for vaccine development.

Authors:  Mei-Liang Huang; Pai-Shan Chiang; Min-Yuan Chia; Shu-Ting Luo; Luan-Yin Chang; Tzou-Yien Lin; Mei-Shang Ho; Min-Shi Lee
Journal:  PLoS Negl Trop Dis       Date:  2013-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.